Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.

Leukemia & lymphoma - 1 Nov 2008

Morilla Alison, Gonzalez de Castro David, Del Giudice Ilaria, Osuji Nnenna, Else Monica, Morilla Ricardo, Brito Babapulle Vasantha, Rudenko Hannah, Matutes Estella, Dearden Claire, Catovsky Daniel, Morgan Gareth J

Abstract excerpt

ZAP-70, CD38 and IGHV mutations have all been reported to have prognostic impact in chronic lymphocytic leukemia (CLL), both individually and in paired combinations. We aimed to determine whether the combination of all three factors provided more refined prognostic information concerning the trea...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Genes, Immunoglobulin Heavy Chain

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Predictive Value of Tests

Share to Prognosis

Share to ZAP-70 Protein-Tyrosine Kinase

Source

Identifiers

PMID: 19021053
DOI: 10.1080/10428190802360810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19021053-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.PMID 19021053Read ↗

ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.Semantic proximity Read ↗

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.Semantic proximity Read ↗

Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).Semantic proximity Read ↗

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.Semantic proximity Read ↗

Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice.Semantic proximity Read ↗

ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.Semantic proximity Read ↗

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.Semantic proximity Read ↗

Predicting Progression--ZAP-70 in CLL.Semantic proximity Read ↗

Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.